These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 9792705)

  • 1. Mitogen-activated protein kinase phosphorylates and regulates the HIV-1 Vif protein.
    Yang X; Gabuzda D
    J Biol Chem; 1998 Nov; 273(45):29879-87. PubMed ID: 9792705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphorylation of Vif and its role in HIV-1 replication.
    Yang X; Goncalves J; Gabuzda D
    J Biol Chem; 1996 Apr; 271(17):10121-9. PubMed ID: 8626571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of human immunodeficiency virus type 1 infectivity by the ERK mitogen-activated protein kinase signaling pathway.
    Yang X; Gabuzda D
    J Virol; 1999 Apr; 73(4):3460-6. PubMed ID: 10074203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The tyrosine kinase Hck is an inhibitor of HIV-1 replication counteracted by the viral vif protein.
    Hassaïne G; Courcoul M; Bessou G; Barthalay Y; Picard C; Olive D; Collette Y; Vigne R; Decroly E
    J Biol Chem; 2001 May; 276(20):16885-93. PubMed ID: 11278465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biological activity of human immunodeficiency virus type 1 Vif requires membrane targeting by C-terminal basic domains.
    Goncalves J; Shi B; Yang X; Gabuzda D
    J Virol; 1995 Nov; 69(11):7196-204. PubMed ID: 7474141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of human immunodeficiency virus type 1 Vif with APOBEC3G is not dependent on serine/threonine phosphorylation status.
    Kopietz F; Jaguva Vasudevan AA; Krämer M; Muckenfuss H; Sanzenbacher R; Cichutek K; Flory E; Münk C
    J Gen Virol; 2012 Nov; 93(Pt 11):2425-2430. PubMed ID: 22894923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human immunodeficiency virus type 1 Vif protein is an integral component of an mRNP complex of viral RNA and could be involved in the viral RNA folding and packaging process.
    Zhang H; Pomerantz RJ; Dornadula G; Sun Y
    J Virol; 2000 Sep; 74(18):8252-61. PubMed ID: 10954522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction and co-encapsidation of human immunodeficiency virus type 1 Gag and Vif recombinant proteins.
    Huvent I; Hong SS; Fournier C; Gay B; Tournier J; Carrière C; Courcoul M; Vigne R; Spire B; Boulanger P
    J Gen Virol; 1998 May; 79 ( Pt 5)():1069-81. PubMed ID: 9603321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. gag, vif, and nef genes contribute to the homologous viral interference induced by a nonproducer human immunodeficiency virus type 1 (HIV-1) variant: identification of novel HIV-1-inhibiting viral protein mutants.
    D'Aloja P; Olivetta E; Bona R; Nappi F; Pedacchia D; Pugliese K; Ferrari G; Verani P; Federico M
    J Virol; 1998 May; 72(5):4308-19. PubMed ID: 9557721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subtle mutations in the cysteine region of HIV-1 Vif drastically alter the viral replication phenotype.
    Fujita M; Sakurai A; Yoshida A; Matsumoto S; Miyaura M; Adachi A
    Microbes Infect; 2002 May; 4(6):621-4. PubMed ID: 12048031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A single amino acid substitution in human APOBEC3G antiretroviral enzyme confers resistance to HIV-1 virion infectivity factor-induced depletion.
    Xu H; Svarovskaia ES; Barr R; Zhang Y; Khan MA; Strebel K; Pathak VK
    Proc Natl Acad Sci U S A; 2004 Apr; 101(15):5652-7. PubMed ID: 15054139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphorylation of APOBEC3G by protein kinase A regulates its interaction with HIV-1 Vif.
    Shirakawa K; Takaori-Kondo A; Yokoyama M; Izumi T; Matsui M; Io K; Sato T; Sato H; Uchiyama T
    Nat Struct Mol Biol; 2008 Nov; 15(11):1184-91. PubMed ID: 18836454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ring finger protein ZIN interacts with human immunodeficiency virus type 1 Vif.
    Feng F; Davis A; Lake JA; Carr J; Xia W; Burrell C; Li P
    J Virol; 2004 Oct; 78(19):10574-81. PubMed ID: 15367624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravirion processing of the human immunodeficiency virus type 1 Vif protein by the viral protease may be correlated with Vif function.
    Khan MA; Akari H; Kao S; Aberham C; Davis D; Buckler-White A; Strebel K
    J Virol; 2002 Sep; 76(18):9112-23. PubMed ID: 12186895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of human immunodeficiency virus type 1 (HIV-1) replication by a two-amino-acid insertion in HIV-1 Vif from a nonprogressing mother and child.
    Alexander L; Aquino-DeJesus MJ; Chan M; Andiman WA
    J Virol; 2002 Oct; 76(20):10533-9. PubMed ID: 12239333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein.
    Sheehy AM; Gaddis NC; Choi JD; Malim MH
    Nature; 2002 Aug; 418(6898):646-50. PubMed ID: 12167863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutational alteration of human immunodeficiency virus type 1 Vif allows for functional interaction with nonhuman primate APOBEC3G.
    Schröfelbauer B; Senger T; Manning G; Landau NR
    J Virol; 2006 Jun; 80(12):5984-91. PubMed ID: 16731937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitogen-activated protein (MAP) kinase phosphorylation of MAP kinase kinase: determination of phosphorylation sites by mass spectrometry and site-directed mutagenesis.
    Mansour SJ; Resing KA; Candi JM; Hermann AS; Gloor JW; Herskind KR; Wartmann M; Davis RJ; Ahn NG
    J Biochem; 1994 Aug; 116(2):304-14. PubMed ID: 7822248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of two distinct human immunodeficiency virus type 1 Vif determinants critical for interactions with human APOBEC3G and APOBEC3F.
    Russell RA; Pathak VK
    J Virol; 2007 Aug; 81(15):8201-10. PubMed ID: 17522216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of vif mutations on cell-free infectivity and replication of simian immunodeficiency virus.
    Park IW; Myrick K; Sodroski J
    J Acquir Immune Defic Syndr (1988); 1994 Dec; 7(12):1228-36. PubMed ID: 7965633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.